Xiangxiang Ma, a partner of Anjie Broad Law Firm, explores the various ways in which a recent U.S. executive order on drug pricing is impacting Chinese pharmaceutical companies’ license-out model ...

Chinese EV giant BYD investigated in U.S. for alleged ties to Chinese Communist Party; European companies more pessimistic ...

Main contents: For the purposes of these Provisions, the phrase “rights holder taking appropriate confidentiality measures” means the reasonable confidentiality measures commensurate with factors such ...

Main contents: The Amendment Draft adds new forms in which illegal acts manifest, expands reporting channels, adds greater detail to the conditions for opening a case and concluding an investigation, ...

In Part I of this series, Daisy Duan, Yingjie Yang and Cuishi Li of King & Wood Mallesons introduced the implications of the amended PRC Company Law for Formal Capital Reductions. In Part II, the ...

The reciprocal Hong Kong-mainland China interim measures arrangement allows parties in certain arbitral proceedings to apply directly to each other's respective courts to seek interim measures before ...

Jun Luo, Director of the Legal and Compliance Department at Shanghai SSCI Leading Fund Co., Ltd, and Taolue Zhang, Vice-Professor and Director of Tongji Intellectual Property and Competition Law ...

In a lengthy reasoned judgment in the case of re Yangtze River Pharma et al. v HIPI Pharma, the Supreme People's Court ruled on three IP-related or novel antitrust issues The court also flagged the ...

2024 marked the establishment of a comprehensive framework for cross-border data transfers, and the issuing of regulations on the administration of network data security In addition to national ...

-The continuing trend is for a widening of the scope of data which will not require onerous ex ante/ex post procedures “There are typically no specific restrictions on the export of general business ...